Tuesday, March 17, 2026

Cigna’s Preferred Drug List: How Celltrion’s Zymentra is Revolutionizing Autoimmune Treatment in 2026

Celltrion's Zymentra added to Evernorth's formulary, boosting access and sales potential in the U.S. autoimmune treatment market.

Will Novo Nordisk’s 50% Price Cut on Wegovy Spark a Price War in Korea’s Obesity Drug Market?

Novo Nordisk's price cuts for GLP-1 obesity treatments in the U.S. may influence South Korean market dynamics, though immediate effects seem limited.

SK On Secures 50% of Domestic ESS Contracts: What This Means for North America in 2026

SK On secures half of a major ESS contract in South Korea, aiming to expand into the North American market with new supply chains.

Tag: Ri Se Ung

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.